These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2819707

  • 1. Differential metabolism of 9-beta-D-arabinofuranosylguanine in human leukemic cells.
    Shewach DS, Mitchell BS.
    Cancer Res; 1989 Dec 01; 49(23):6498-502. PubMed ID: 2819707
    [Abstract] [Full Text] [Related]

  • 2. Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts.
    Verhoef V, Fridland A.
    Cancer Res; 1985 Aug 01; 45(8):3646-50. PubMed ID: 2410098
    [Abstract] [Full Text] [Related]

  • 3. Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts.
    Shewach DS, Daddona PE, Ashcraft E, Mitchell BS.
    Cancer Res; 1985 Mar 01; 45(3):1008-14. PubMed ID: 3971358
    [Abstract] [Full Text] [Related]

  • 4. Guanine arabinoside as a bone marrow-purging agent.
    Kurtzberg J.
    Ann N Y Acad Sci; 1993 Jun 23; 685():225-36. PubMed ID: 8363226
    [Abstract] [Full Text] [Related]

  • 5. Dual mechanisms of 9-beta-D-arabinofuranosylguanine resistance in CEM T-lymphoblast leukemia cells.
    Curbo S, Zhu C, Johansson M, Balzarini J, Karlsson A.
    Biochem Biophys Res Commun; 2001 Jul 06; 285(1):40-5. PubMed ID: 11437369
    [Abstract] [Full Text] [Related]

  • 6. Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma.
    Wiley JS, Taupin J, Jamieson GP, Snook M, Sawyer WH, Finch LR.
    J Clin Invest; 1985 Feb 06; 75(2):632-42. PubMed ID: 3871794
    [Abstract] [Full Text] [Related]

  • 7. Clinically relevant deoxycytidine levels are high enough to profoundly alter 9-beta-D-arabinofuranosylguanine cytotoxicity for human T-cell acute leukemia cells in vitro.
    Cohen JD, Strock DJ, Teik JE, LaGuardia EA, Katz TB.
    Pediatr Hematol Oncol; 1999 Feb 06; 16(3):239-44. PubMed ID: 10326222
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Activation of guanine-β-D-arabinofuranoside and deoxyguanosine to triphosphates by a common pathway blocks T lymphoblasts at different checkpoints.
    Leanza L, Miazzi C, Ferraro P, Reichard P, Bianchi V.
    Exp Cell Res; 2010 Dec 10; 316(20):3443-53. PubMed ID: 20603113
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5'-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Plunkett W, Dixon DO.
    Cancer Res; 1985 Nov 10; 45(11 Pt 2):5952-7. PubMed ID: 4053067
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in leukemic cells after intravenous and subcutaneous administration of 1-beta-D-arabinofuranosylcytosine.
    Liliemark JO, Paul CY, Gahrton CG, Peterson CO.
    Cancer Res; 1985 May 10; 45(5):2373-5. PubMed ID: 3986778
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.